{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:36:25Z","timestamp":1772825785241,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondo de Desarrollo Cientifico (FODECIJAL) 2019 from Consejo Estatal de Ciencia y Tecnolog\u00eda de Jalisco","award":["1702512-8152"],"award-info":[{"award-number":["1702512-8152"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The muscle fiber ultrastructure in Idiopathic Inflammatory Myopathies (IIM) has been scarcely explored, especially in Inclusion Body Myositis. The aim of this study was to implement the Scanning Electron Microscopy (SEM) in a small cohort of IIM patients, together with the characterization of immunological profile for a better understanding of the pathophysiology. For immunological profile characterization, we identified the presence of autoantibodies (Ro-52, OJ, EJ, PL7, PL12, SRP, Jo-1, PMScl75, PMScl100, Ku, SAE1, NXP2, MDA5, TIF1\u03b3, Mi-2\u03b1, Mi-2\u03b2) and quantified cytokines (IL-1\u03b2, IFN-\u03b12, IFN-\u03b3, TNF-\u03b1, IL-6, IL-10, IL-12p70, IL-17A, IL-18, IL-23, IL-33) and chemokines (CCL2, CXCL8). The histological analysis was made by hematoxylin\u2013eosin staining while the muscle fiber ultrastructure was characterized by SEM. We observed changes in the morphology and structure of the muscle fiber according to muscle strength and muscle enzymes. We were able to find and describe muscle fiber ultrastructure with marked irregularities, porosities, disruption in the linearity and integrity of the fascicle, more evident in patients with increased serum levels of muscle enzymes and diminished muscle strength. Despite the scarce reports about the use of SEM as a tool in all clinical phenotypes of IIM, our work provides an excellent opportunity to discuss and reframe the clinical usefulness of SEM in the diagnostic approach of IIM.<\/jats:p>","DOI":"10.1038\/s41598-022-22754-4","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:06:36Z","timestamp":1666353996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impaired muscle strength is associated with ultrastructure damage in myositis"],"prefix":"10.1038","volume":"12","author":[{"given":"Andrea","family":"Aguilar-Vazquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrain","family":"Chavarria-Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Salazar-Paramo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Armendariz-Borunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Toriz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Rodr\u00edguez-Baeza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sandoval-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisbeth","family":"Villanueva-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisol","family":"God\u00ednez-Rub\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose-David","family":"Medina-Preciado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesenia","family":"Lozano-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia-Alejandra","family":"Gomez-Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Pizano-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika-Aurora","family":"Martinez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz-Teresita","family":"Martin-Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Duran-Barragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda-Lucia","family":"Palacios-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcelia","family":"Llamas-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livier","family":"G\u00f3mez-Lim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Vazquez-Del Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"22754_CR1","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg, I. E. et al. 2017 European league against rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann. Rheum. Dis. 76, 1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"22754_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1756-185X.2010.01472.x","volume":"13","author":"S Cox","year":"2010","unstructured":"Cox, S., Limaye, V., Hill, C., Blumbergs, P. & Roberts-Thomson, P. Idiopathic inflammatory myopathies: Diagnostic criteria, classification and epidemiological features. Int. J. Rheum. Dis. 13, 117\u2013124. https:\/\/doi.org\/10.1111\/j.1756-185X.2010.01472.x (2010).","journal-title":"Int. J. Rheum. Dis."},{"key":"22754_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/BRS.0000000000003602","volume":"45","author":"WB Jiang","year":"2020","unstructured":"Jiang, W. B. et al. Scanning electron microscopic observation of myodural bridge in the human suboccipital region. Spine 45, 1296\u20131301. https:\/\/doi.org\/10.1097\/BRS.0000000000003602 (2020).","journal-title":"Spine"},{"key":"22754_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.aanat.2018.11.004","volume":"222","author":"T Sandulescu","year":"2019","unstructured":"Sandulescu, T., Buechner, H., Rauscher, D., Naumova, E. A. & Arnold, W. H. Histological, SEM and three-dimensional analysis of the midfacial SMAS\u2014new morphological insights. Ann. Anat. 222, 70\u201378. https:\/\/doi.org\/10.1016\/j.aanat.2018.11.004 (2019).","journal-title":"Ann. Anat."},{"key":"22754_CR5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1167\/iovs.17-23003","volume":"59","author":"LK McLoon","year":"2018","unstructured":"McLoon, L. K., Vicente, A., Fitzpatrick, K. R., Lindstrom, M. & Pedrosa Domellof, F. Composition, architecture, and functional implications of the connective tissue network of the extraocular muscles. Invest. Ophthalmol. Vis. Sci. 59, 322\u2013329. https:\/\/doi.org\/10.1167\/iovs.17-23003 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"22754_CR6","doi-asserted-by":"publisher","first-page":"30610","DOI":"10.1038\/srep30610","volume":"6","author":"AE Vincent","year":"2016","unstructured":"Vincent, A. E. et al. The spectrum of mitochondrial ultrastructural defects in mitochondrial myopathy. Sci. Rep. 6, 30610. https:\/\/doi.org\/10.1038\/srep30610 (2016).","journal-title":"Sci. Rep."},{"key":"22754_CR7","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00296-018-4221-z","volume":"39","author":"K Haczkiewicz","year":"2019","unstructured":"Haczkiewicz, K. et al. Immunohistochemical and ultrastructural analysis of sporadic inclusion body myositis: A case series. Rheumatol. Int. 39, 1291\u20131301. https:\/\/doi.org\/10.1007\/s00296-018-4221-z (2019).","journal-title":"Rheumatol. Int."},{"key":"22754_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/brain\/102.4.701","volume":"102","author":"S Matsubara","year":"1979","unstructured":"Matsubara, S. & Mair, W. G. Ultrastructural changes in polymyositis. Brain 102, 701\u2013725. https:\/\/doi.org\/10.1093\/brain\/102.4.701 (1979).","journal-title":"Brain"},{"key":"22754_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13317-014-0063-1","volume":"5","author":"L Iaccarino","year":"2014","unstructured":"Iaccarino, L. et al. Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation. Auto Immun. Highlights 5, 87\u201394. https:\/\/doi.org\/10.1007\/s13317-014-0063-1 (2014).","journal-title":"Auto Immun. Highlights"},{"key":"22754_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider, L. G. et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res. 62, 465\u2013472. https:\/\/doi.org\/10.1002\/acr.20035 (2010).","journal-title":"Arthritis Care Res."},{"key":"22754_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061580","author":"MJ Wu","year":"2022","unstructured":"Wu, M. J., Liao, W. A., Lin, P. Y. & Sun, Y. T. Muscle biopsy: A requirement for precision medicine in adult-onset myopathy. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm11061580 (2022).","journal-title":"J. Clin. Med."},{"key":"22754_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J. & Chan, E. K. A comprehensive overview on myositis-specific antibodies: New and old biomarkers in idiopathic inflammatory myopathy. Clin. Rev. Allergy Immunol. 52, 1\u201319. https:\/\/doi.org\/10.1007\/s12016-015-8510-y (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"22754_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","author":"L Cavagna","year":"2019","unstructured":"Cavagna, L. et al. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm8112013 (2019).","journal-title":"J. Clin. Med."},{"key":"22754_CR14","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb. Perspect. Biol. 6, a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"22754_CR15","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas, M. C. Inflammatory muscle diseases. N. Engl. J. Med. 372, 1734\u20131747. https:\/\/doi.org\/10.1056\/NEJMra1402225 (2015).","journal-title":"N. Engl. J. Med."},{"key":"22754_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155238","author":"F Pandolfi","year":"2020","unstructured":"Pandolfi, F. et al. Interleukin 6 in rheumatoid arthritis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21155238 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"22754_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1590\/1806-9282.20210665","volume":"67","author":"TS Melo","year":"1992","unstructured":"Melo, T. S., Silva, M. L. E., Silva Junior, M. L. M., Duarte, A. P. & Gueiros, L. A. (2021) Characterization of clinical, laboratory, IL-6 serum levels, and IL-6\u2013174 G\/C genetic polymorphisms in patients with rheumatoid arthritis and Sjogren\u2019s syndrome. Rev. Assoc. Med. Bras. 67, 1600\u20131604. https:\/\/doi.org\/10.1590\/1806-9282.20210665 (1992).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"22754_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1517\/14728222.8.4.287","volume":"8","author":"H Ito","year":"2004","unstructured":"Ito, H. Novel therapy for Crohn\u2019s disease targeting IL-6 signalling. Expert Opin. Ther. Targets 8, 287\u2013294. https:\/\/doi.org\/10.1517\/14728222.8.4.287 (2004).","journal-title":"Expert Opin. Ther. Targets"},{"key":"22754_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2006.03.026","volume":"176","author":"F Scuderi","year":"2006","unstructured":"Scuderi, F., Mannella, F., Marino, M., Provenzano, C. & Bartoccioni, E. IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis. J. Neuroimmunol. 176, 9\u201315. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.03.026 (2006).","journal-title":"J. Neuroimmunol."},{"key":"22754_CR20","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic, H. et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 60, 3436\u20133446. https:\/\/doi.org\/10.1002\/art.24936 (2009).","journal-title":"Arthritis Rheum."},{"key":"22754_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cyto.2014.11.026","volume":"73","author":"A Arshanapalli","year":"2015","unstructured":"Arshanapalli, A., Shah, M., Veerula, V. & Somani, A. K. The role of type I interferons and other cytokines in dermatomyositis. Cytokine 73, 319\u2013325. https:\/\/doi.org\/10.1016\/j.cyto.2014.11.026 (2015).","journal-title":"Cytokine"},{"key":"22754_CR22","first-page":"656","volume":"37","author":"MG Silva","year":"2019","unstructured":"Silva, M. G., Oba-Shinjo, S. M., Marie, S. K. N. & Shinjo, S. K. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clin. Exp. Rheumatol. 37, 656\u2013662 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"22754_CR23","first-page":"450","volume":"63","author":"DA Isenberg","year":"1986","unstructured":"Isenberg, D. A., Rowe, D., Shearer, M., Novick, D. & Beverley, P. C. Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy. Clin. Exp. Immunol. 63, 450\u2013458 (1986).","journal-title":"Clin. Exp. Immunol."},{"key":"22754_CR24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg, I. E. et al. European league against rheumatism\/american college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271\u20132282. https:\/\/doi.org\/10.1002\/art.40320 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"22754_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-024-0921-5_1","volume":"941","author":"J Fenimore","year":"2016","unstructured":"Fenimore, J. & Young, H. A. Regulation of IFN-gamma expression. Adv. Exp. Med. Biol. 941, 1\u201319. https:\/\/doi.org\/10.1007\/978-94-024-0921-5_1 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"22754_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.ajpath.2011.05.055","volume":"179","author":"J Ivanidze","year":"2011","unstructured":"Ivanidze, J. et al. Inclusion body myositis: Laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. Am. J. Pathol. 179, 1347\u20131359. https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.055 (2011).","journal-title":"Am. J. Pathol."},{"key":"22754_CR27","first-page":"503","volume":"136","author":"R Hohlfeld","year":"1990","unstructured":"Hohlfeld, R. & Engel, A. G. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am. J. Pathol. 136, 503\u2013508 (1990).","journal-title":"Am. J. Pathol."},{"key":"22754_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaut.2016.08.004","volume":"75","author":"S Bhattarai","year":"2016","unstructured":"Bhattarai, S. et al. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. J. Autoimmun. 75, 118\u2013129. https:\/\/doi.org\/10.1016\/j.jaut.2016.08.004 (2016).","journal-title":"J. Autoimmun."},{"key":"22754_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","volume":"15","author":"SA Greenberg","year":"2019","unstructured":"Greenberg, S. A. Inclusion body myositis: Clinical features and pathogenesis. Nat. Rev. Rheumatol. 15, 257\u2013272. https:\/\/doi.org\/10.1038\/s41584-019-0186-x (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"22754_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 29, 313\u2013326. https:\/\/doi.org\/10.1089\/jir.2008.0027 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"22754_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s004010051041","volume":"97","author":"A Liprandi","year":"1999","unstructured":"Liprandi, A., Bartoli, C., Figarella-Branger, D., Pellissier, J. F. & Lepidi, H. Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol. 97, 642\u2013648. https:\/\/doi.org\/10.1007\/s004010051041 (1999).","journal-title":"Acta Neuropathol."},{"key":"22754_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1043\/1543-2165(2008)132[232:MIAOCI]2.0.CO;210.5858\/2008-132-232-MIAOCI","volume":"132","author":"GS Baird","year":"2008","unstructured":"Baird, G. S. & Montine, T. J. Multiplex immunoassay analysis of cytokines in idiopathic inflammatory myopathy. Arch. Pathol. Lab. Med. 132, 232\u2013238. https:\/\/doi.org\/10.1043\/1543-2165(2008)132[232:MIAOCI]2.0.CO;210.5858\/2008-132-232-MIAOCI (2008).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"22754_CR33","first-page":"204","volume":"44","author":"F Chen","year":"2012","unstructured":"Chen, F., Shu, X. M., Wang, D. X., Wang, G. C. & Lu, X. Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits\/dermatomyosits. Beijing Da Xue Xue Bao Yi Xue Ban 44, 204\u2013208 (2012).","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"22754_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40001-019-0368-7","volume":"24","author":"CY Wu","year":"2019","unstructured":"Wu, C. Y., Li, L. & Zhang, L. H. Detection of serum MCP-1 and TGF-beta1 in polymyositis\/dermatomyositis patients and its significance. Eur. J. Med. Res. 24, 12. https:\/\/doi.org\/10.1186\/s40001-019-0368-7 (2019).","journal-title":"Eur. J. Med. Res."},{"key":"22754_CR35","doi-asserted-by":"publisher","first-page":"e1328337","DOI":"10.1080\/2162402X.2017.1328337","volume":"6","author":"E Timperi","year":"2017","unstructured":"Timperi, E. et al. IL-18 receptor marks functional CD8(+) T cells in non-small cell lung cancer. Oncoimmunology 6, e1328337. https:\/\/doi.org\/10.1080\/2162402X.2017.1328337 (2017).","journal-title":"Oncoimmunology"},{"key":"22754_CR36","doi-asserted-by":"publisher","first-page":"e1002273","DOI":"10.1371\/journal.ppat.1002273","volume":"7","author":"JT Ingram","year":"2011","unstructured":"Ingram, J. T., Yi, J. S. & Zajac, A. J. Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections. Plos Pathog. 7, e1002273. https:\/\/doi.org\/10.1371\/journal.ppat.1002273 (2011).","journal-title":"Plos Pathog."},{"key":"22754_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2249.2006.03180.x","volume":"146","author":"M Tucci","year":"2006","unstructured":"Tucci, M., Quatraro, C., Dammacco, F. & Silvestris, F. Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies. Clin. Exp. Immunol. 146, 21\u201331. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03180.x (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"22754_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1196\/annals.1381.020","volume":"1107","author":"M Tucci","year":"2007","unstructured":"Tucci, M., Quatraro, C., Dammacco, F. & Silvestris, F. Increased IL-18 production by dendritic cells in active inflammatory myopathies. Ann. N. Y. Acad. Sci. 1107, 184\u2013192. https:\/\/doi.org\/10.1196\/annals.1381.020 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"22754_CR39","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen, T. & Cidlowski, J. A. Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs. N. Engl. J. Med. 353, 1711\u20131723. https:\/\/doi.org\/10.1056\/NEJMra050541 (2005).","journal-title":"N. Engl. J. Med."},{"key":"22754_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","volume":"10","author":"RC Russo","year":"2014","unstructured":"Russo, R. C., Garcia, C. C., Teixeira, M. M. & Amaral, F. A. The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev. Clin. Immunol. 10, 593\u2013619. https:\/\/doi.org\/10.1586\/1744666X.2014.894886 (2014).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"22754_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","volume":"135","author":"C Tang","year":"2012","unstructured":"Tang, C., Chen, S., Qian, H. & Huang, W. Interleukin-23: As a drug target for autoimmune inflammatory diseases. Immunology 135, 112\u2013124. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03522.x (2012).","journal-title":"Immunology"},{"key":"22754_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/03009742.2010.517215","volume":"40","author":"H Shen","year":"2011","unstructured":"Shen, H., Xia, L., Lu, J. & Xiao, W. Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis. Scand. J. Rheumatol. 40, 217\u2013220. https:\/\/doi.org\/10.3109\/03009742.2010.517215 (2011).","journal-title":"Scand. J. Rheumatol."},{"key":"22754_CR43","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1038\/s41598-018-23539-4","volume":"8","author":"N Umezawa","year":"2018","unstructured":"Umezawa, N. et al. Interleukin-23 as a therapeutic target for inflammatory myopathy. Sci. Rep. 8, 5498. https:\/\/doi.org\/10.1038\/s41598-018-23539-4 (2018).","journal-title":"Sci. Rep."},{"key":"22754_CR44","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1097\/RHU.0000000000001515","volume":"27","author":"E Chavarria-Avila","year":"2021","unstructured":"Chavarria-Avila, E. et al. Going further: Comprehensive disease control of rheumatoid arthritis, targeting cytokines and chemokines. J. Clin. Rheumatol. 27, e432\u2013e439. https:\/\/doi.org\/10.1097\/RHU.0000000000001515 (2021).","journal-title":"J. Clin. Rheumatol."},{"issue":"Suppl 11","key":"22754_CR45","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider, L. G. et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and patient\/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)\/childhood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous dermatomyositis disease area and severity index (CDASI), cutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and dermatology life quality index (DLQI). Arthritis Care Res. 63(Suppl 11), S118-157. https:\/\/doi.org\/10.1002\/acr.20532 (2011).","journal-title":"Arthritis Care Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22754-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22754-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:16:17Z","timestamp":1666354577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22754-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22754"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22754-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17671"}}